Organon Outlines Importance Of Speed For US Humira Opportunity
Former Merck Company Also Divulges Interchangeability Expectations
At its debut year-end financial earnings call, Organon spoke in further detail about the impending launch of Humira biosimilars, as well as its desire to continue growing its portfolio.
